scispace - formally typeset
Z

Zhongjian Cheng

Researcher at Temple University

Publications -  40
Citations -  2090

Zhongjian Cheng is an academic researcher from Temple University. The author has contributed to research in topics: Endothelial dysfunction & Endothelium. The author has an hindex of 25, co-authored 40 publications receiving 1691 citations. Previous affiliations of Zhongjian Cheng include New York University & University of Calgary.

Papers
More filters
Journal Article

Angiotensin II and vascular inflammation.

TL;DR: The pro-inflammatory action of Ang II may help to understand the molecular mechanisms of hypertension- and diabetes-induced vascular complication as well as the pleiotropic actions of drugs interfering with RAS.
Journal ArticleDOI

Endothelial Dysfunction and Salt-Sensitive Hypertension in Spontaneously Diabetic Goto-Kakizaki Rats

TL;DR: It is concluded that hypertension in GK rats is salt sensitive and associated with endothelial dysfunction and perivascular inflammation and AT1 receptor blockade ameliorates inflammation during a low-sodium diet and partially protects against salt-induced vascular damage by blood pressure–independent mechanisms.
Journal ArticleDOI

Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes

TL;DR: Overproduction of Ang II in dTGR induces pronounced endothelial dysfunction, whereas the sensitivity of vascular smooth muscle cells to nitric oxide is unaltered, suggesting hypertension-associated generalized changes in the vascular function rather than a receptor-specific desensitization.
Journal ArticleDOI

Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function.

TL;DR: It is suggested that anti-inflammatory/immunosuppressive cytokines serve as novel therapeutic targets for inhibiting endothelial dysfunction, vascular inflammation and cardio- and cerebro-vascular diseases.